These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30221124)

  • 1. Positive and negative AIT trials: What makes the difference?
    Gerth van Wijk R
    Allergo J Int; 2018; 27(6):167-172. PubMed ID: 30221124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
    Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
    Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?
    Pfaar O; Gerth van Wijk R
    Curr Treat Options Allergy; 2015; 2(1):1-9. PubMed ID: 25798370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives in allergen immunotherapy: 2019 and beyond.
    Pfaar O; Agache I; de Blay F; Bonini S; Chaker AM; Durham SR; Gawlik R; Hellings PW; Jutel M; Kleine-Tebbe J; Klimek L; Kopp MV; Nandy A; Rabin RL; van Ree R; Renz H; Roberts G; Salapatek AM; Schmidt-Weber CB; Shamji MH; Sturm GJ; Virchow JC; Wahn U; Willers C; Zieglmayer P; Akdis CA
    Allergy; 2019 Dec; 74 Suppl 108():3-25. PubMed ID: 31872476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials in allergen immunotherapy: current concepts and future needs.
    Pfaar O; Alvaro M; Cardona V; Hamelmann E; Mösges R; Kleine-Tebbe J
    Allergy; 2018 Sep; 73(9):1775-1783. PubMed ID: 29446469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ
    Vitiello G; Maltagliati L; Rossi O
    Clin Mol Allergy; 2020; 18():10. PubMed ID: 32536827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular approaches to allergen-specific immunotherapy: Are we so far from clinical implementation?
    Pechsrichuang P; Jacquet A
    Clin Exp Allergy; 2020 May; 50(5):543-557. PubMed ID: 32078207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.
    Shamji MH; Kappen JH; Akdis M; Jensen-Jarolim E; Knol EF; Kleine-Tebbe J; Bohle B; Chaker AM; Till SJ; Valenta R; Poulsen LK; Calderon MA; Demoly P; Pfaar O; Jacobsen L; Durham SR; Schmidt-Weber CB
    Allergy; 2017 Aug; 72(8):1156-1173. PubMed ID: 28152201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview.
    Asaria M; Dhami S; van Ree R; Gerth van Wijk R; Muraro A; Roberts G; Sheikh A
    Allergy; 2018 Feb; 73(2):269-283. PubMed ID: 28718981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles.
    Nelson HS; Calderon MA; Bernstein DI; Casale TB; Durham SR; Andersen JS; Esch R; Cox LS; Nolte H
    Curr Allergy Asthma Rep; 2017 Mar; 17(3):18. PubMed ID: 28293909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USA.
    Guan K; Liu B; Wang M; Li Z; Chang C; Cui L; Wang RQ; Wen LP; Leung PSC; Wei JF; Sun JL
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):128-143. PubMed ID: 31243705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis.
    Feng M; Zeng X; Li J
    J Thorac Dis; 2019 Aug; 11(8):3616-3625. PubMed ID: 31559069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper.
    Pfaar O; Demoly P; Gerth van Wijk R; Bonini S; Bousquet J; Canonica GW; Durham SR; Jacobsen L; Malling HJ; Mösges R; Papadopoulos NG; Rak S; Rodriguez del Rio P; Valovirta E; Wahn U; Calderon MA;
    Allergy; 2014 Jul; 69(7):854-67. PubMed ID: 24761804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen Immunotherapy in Pediatric Asthma: A Pragmatic Point of View.
    Miraglia Del Giudice M; Licari A; Brambilla I; Tosca MA; Ciprandi G
    Children (Basel); 2020 Jun; 7(6):. PubMed ID: 32521598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen immunotherapy phase II trials: Challenges in dose finding.
    Kleine-Tebbe J; Kaul S; Mösges R
    Allergol Select; 2019; 3(1):1-8. PubMed ID: 32176223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen immunotherapy and asthma: efficacy, safety, and other considerations.
    Cox L
    Allergy Asthma Proc; 2008; 29(6):580-9. PubMed ID: 19173785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials in allergen immunotherapy in the age group of children and adolescents: current concepts and future needs.
    Pfaar O; Gerth van Wijk R; Klimek L; Bousquet J; Creticos PS
    Clin Transl Allergy; 2020; 10():11. PubMed ID: 32346471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
    Hesse L; Petersen AH; Nawijn MC
    Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient selection for subcutaneous versus sublingual immunotherapy.
    Larenas-Linnemann D
    Curr Opin Allergy Clin Immunol; 2015 Dec; 15(6):588-95. PubMed ID: 26485098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.